The King of Norway has presented a USA scientist with that nation’s top lifetime achievement award in cancer research.
Dr. Oystein Fodstad, scientific director of the USA Mitchell Cancer Institute and Barbara Colle Chair, received the award from King Harald V of Norway earlier this month at a gala event in Oslo.
The internationally recognized award was established in 1992 by the Norwegian Cancer Society in memory of King Olav V, father of King Harald V, who died in 1991. Fodstad was nominated and chosen for the year’s sole prize by an independent panel of experts based on his scientific contributions to cancer research throughout his career. The King Olav V prize consists of the diploma and a $125,000 cash award.
“We’re extremely proud of Fodstad as a friend and colleague,” said Dr. Michael Boyd, Abraham Mitchell Chair and director of the USA Mitchell Cancer Institute. “It reflects wonderfully on his leadership role in the Mitchell Cancer Institute.”
About 250 people attended the invitation-only event in Oslo, which included an opera performance, testimonials by cancer survivors and a dinner reception in a 300-year-old stateroom.
Fodstad said he was honored by the award from his homeland because it highlights the collaboration he has had with other researchers throughout his career.
“It recognizes that you have done something meaningful, and that our work has had some impact on cancer diagnosis and treatment,” he said.
Before joining USA’s Mitchell Cancer Institute in 2003, Fodstad served as director of the Institute for Cancer Research at The Norwegian Radium Hospital in Oslo, Norway’s national cancer research center. Fodstad also served as head of the department of tumor biology there for 15 years. He was also a professor in experimental cancer chemotherapy at the University of Oslo.
A native of Skreia, Norway, Fodstad earned his M.D. in 1967 and his Ph.D. in 1980, both from the University of Oslo. He and Boyd met in the early 1980s at the National Cancer Institute in Bethesda, Md.
USA Mitchell Cancer Institute
Begun in 2000, USA’s Mitchell Cancer Institute was created to provide the upper Gulf Coast region with comprehensive cancer education, prevention and treatment services in an academic research setting. Primary objectives include developing innovative new treatments and becoming a National Cancer Institute designated research center. The Institute has received more than $125 million in public and private funds, including assistance from Mobile City, Mobile County, federal and state support, USA Foundation and private giving.
For more information about USA’s Mitchell Cancer Institute, call (251) 460-6993 or go to www.southalabama.edu/mci/.